This NDC is on FDA's drug shortage list (posted Apr 2, 2020)
Reported reason: Demand increase for the drug
Product Information
MIDAZOLAM HCL 2 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.2343 per ML under NDC 63323041112. Its NADAC has been published 236 times since May 20, 2015.
FDA first approved this application on Jun 20, 2000. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323041112
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075154FDA Approved
6/20/2000
TE Code
AP
On Market Since
7/14/2000
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has been published 236 times since May 20, 2015, and over the history we have for it it has declined 24.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2343 per ML |
|---|---|
| All-time high | $0.3151 (Feb 15, 2017) |
| All-time low | $0.1862 (Sep 18, 2024) |
| 52-week high | $0.2408 |
| 52-week low | $0.2246 |
| Median price | $0.2800 |
| Average price | $0.2634 |
| Largest weekly change | -33.5% (Sep 18, 2024) |
| Weeks tracked | 236 |
| Tracking since | May 20, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 2 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 2 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.2343 per ML (NDC 63323041112), effective Aug 19, 2026.
How has the price of MIDAZOLAM HCL 2 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has declined 24.1%. It has been tracked across 236 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 2 MG/2 ML VIAL?
Since May 20, 2015, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has ranged from a low of $0.1862 (Sep 18, 2024) to a high of $0.3151 (Feb 15, 2017), with a median of $0.2800 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 2 MG/2 ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIDAZOLAM HCL 1 MG/ML VIAL, is $0.2185 per ML — about 7% below MIDAZOLAM HCL 2 MG/2 ML VIAL.
Who manufactures MIDAZOLAM HCL 2 MG/2 ML VIAL?
MIDAZOLAM HCL 2 MG/2 ML VIAL (NDC 63323041112) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Is MIDAZOLAM HCL 2 MG/2 ML VIAL in shortage?
Yes — NDC 63323041112 is currently listed in FDA's drug shortage database (posted Apr 2, 2020). Reported reason: Demand increase for the drug.